Literature DB >> 9425596

Molecular genetics of Beckwith-Wiedemann syndrome.

M Li1, J A Squire, R Weksberg.   

Abstract

Beckwith-Wiedemann syndrome (BWS) is an overgrowth disorder characterized by developmental anomalies, tissue and organ hyperplasia, and an increased risk of embryonal tumors. BWS is a multigenic disorder with dysregulation of the expression of imprinted genes involved in growth and cell cycle control in the 11p15 chromosomal region. The molecular genetics appear to involve either mutations of imprinted genes or chromosomal alterations of a putative imprinting center that controls gene expression across a large chromosomal domain. As the molecular genetics underlying BWS are unraveled, our knowledge of this imprinting disorder and its relationship to neoplasia and developmental anomalies will be expanded. Currently available diagnostic testing and follow-up protocols will evolve as our understanding of the molecular basis of this disease progresses.

Entities:  

Mesh:

Year:  1997        PMID: 9425596     DOI: 10.1097/00008480-199712000-00012

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  10 in total

1.  Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome.

Authors:  D Monk; E L Wakeling; V Proud; M Hitchins; S N Abu-Amero; P Stanier; M A Preece; G E Moore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

Authors:  S C Abraham; T T Wu; D S Klimstra; L S Finn; J H Lee; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  Addition of H19 'loss of methylation testing' for Beckwith-Wiedemann syndrome (BWS) increases the diagnostic yield.

Authors:  Jochen K Lennerz; Robert J Timmerman; Dorothy K Grange; Michael R DeBaun; Andrew P Feinberg; Barbara A Zehnbauer
Journal:  J Mol Diagn       Date:  2010-07-08       Impact factor: 5.568

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

Review 5.  Genomic imprinting and chromatin insulation in Beckwith-Wiedemann syndrome.

Authors:  J M Greally
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

6.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

7.  Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.

Authors:  M P Sperandeo; P Ungaro; M Vernucci; P V Pedone; F Cerrato; L Perone; S Casola; M V Cubellis; C B Bruni; G Andria; G Sebastio; A Riccio
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

8.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

9.  Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.

Authors:  Deyin Xing; Karin Miller; Katie Beierl; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2022-01-01       Impact factor: 6.298

10.  A case of familial isolated hemihyperplasia.

Authors:  Heidi A Heilstedt; Carlos A Bacino
Journal:  BMC Med Genet       Date:  2004-02-02       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.